Nano-X Imaging Ltd income statement NNOX
In fiscal 2025, which ended Dec 31, 2025, Nano-X Imaging Ltd reported revenue of $13.0 million, up 15.4% from the year before. It recorded a net loss of $75.0 million. The operating loss came to $78.2 million, an operating margin of -600.8%. Diluted earnings per share were -$1.16. Across the 5 fiscal years shown, revenue grew from $1.3 million in fiscal 2021 to $13.0 million in fiscal 2025, about 77.8% a year.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.
| Line |
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
|---|---|---|---|---|---|---|
| Revenue |
13
+15.4%
|
11
+13.9%
|
10
+15.5%
|
9
+557.8%
|
1
|
—
|
| Cost of revenue |
26
+17.9%
|
22
+32.7%
|
16
+6.7%
|
15
+448.9%
|
3
|
—
|
| Gross profit |
-13
-20.5%
|
-11
-60.9%
|
-7
+4.2%
|
-7
-355.0%
|
-2
|
—
|
| Research and development |
19
-4.7%
|
20
-22.5%
|
26
-1.7%
|
27
+54.8%
|
17
+85.9%
|
9
|
| Selling, general and administrative |
27
+5.4%
|
26
-9.1%
|
28
-37.7%
|
46
+9.3%
|
42
+20.2%
|
35
|
| Other operating income (expense) |
-1
-1481.1%
|
-0
-106.3%
|
1
|
—
|
—
|
—
|
| Operating income |
-78
-37.9%
|
-57
+9.3%
|
-63
+46.8%
|
-118
-91.2%
|
-62
-40.1%
|
-44
|
| Foreign currency gain (loss) |
-0
-129.9%
|
1
+842.0%
|
-0
|
—
|
—
|
—
|
| Other income (expense) |
1
-50.4%
|
3
+73.7%
|
2
|
—
|
—
|
0
|
| Pretax income |
-77
-42.6%
|
-54
+11.8%
|
-61
+47.7%
|
-117
-89.1%
|
-62
|
—
|
| Income tax |
-2
-400.6%
|
-0
-5.6%
|
-0
+90.8%
|
-4
-7562.5%
|
-0
|
—
|
| Net income |
-75
-40.2%
|
-54
+11.9%
|
-61
+46.3%
|
-113
-83.2%
|
-62
-41.0%
|
-44
|
| Basic EPS |
-1.16
-27.5%
|
-0.91
+15.7%
|
-1.08
+50.2%
|
-2.17
-69.5%
|
-1.28
|
—
|
| Diluted EPS |
-1.16
-27.5%
|
-0.91
+15.7%
|
-1.08
+50.2%
|
-2.17
|
—
|
—
|
| Weighted average shares, basic |
0
+10.4%
|
0
+4.1%
|
0
-99.9%
|
52
+108235.4%
|
0
|
—
|
| Weighted average shares, diluted |
0
+10.4%
|
0
|
—
|
—
|
—
|
—
|
| Other measures | ||||||
| Depreciation and amortization |
1
+6.1%
|
1
-6.4%
|
1
+32.4%
|
1
+72.7%
|
1
+151.9%
|
0
|
| EBITDA |
-77
-38.5%
|
-56
+9.4%
|
-61
+47.4%
|
-117
-91.4%
|
-61
-39.6%
|
-44
|
| Margins | ||||||
| Gross margin |
-98.21%
|
-94.03%
|
-66.55%
|
-80.21%
|
-115.95%
|
—
|
| Operating margin |
-600.83%
|
-502.93%
|
-631.89%
|
-1,372.23%
|
-4,720.71%
|
—
|
| Pretax margin |
-589.89%
|
-477.48%
|
-617.01%
|
-1,363.03%
|
-4,742.79%
|
—
|
| Profit margin |
-576.13%
|
-474.31%
|
-613.59%
|
-1,320.16%
|
-4,739.11%
|
—
|
| EBITDA margin |
-591.70%
|
-493.00%
|
-619.80%
|
-1,361.68%
|
-4,680.52%
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- X-Ray Apparatus & Tubes & Related Irradiation Apparatus (SIC 3844)
- Listed as
- NNOX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Petach Tikva, Israel
- SEC filer status
- Accelerated filer
- SEC CIK
- 1795251
Other X-Ray Apparatus & Tubes & Related Irradiation Apparatus companies
All 4 X-Ray Apparatus & Tubes & Related Irradiation Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.